iTeos Therapeutics, Inc. (ITOS) Tops Q3 EPS by 12c

iTeos Therapeutics, Inc. (NASDAQ: ITOS) reported Q3 EPS of ($1.05), $0.12 better than the analyst estimate of ($1.17).

For earnings history and earnings-related data on iTeos Therapeutics, Inc. (ITOS) click here.

You May Also Be Interested In

• Delta Air Lines (DAL) call put ratio 2.2 calls to 1 put into quarter results
• Levi (LEVI) Tops Q2 EPS by 4c, Offers Guidance
• Popular stocks with increasing option volume: AVGO INTC MU SPCX BABA PLTR SOFI MSTR NFLX ORCL